Downregulation of caveolin-1 upregulates the expression of growth factors and regulators in co-culture of fibroblasts with cancer cells

Molecular Medicine Reports

Volumn 13, Issue 1, 2016, Pages 744-752

  Shi, Xiao Yu ^a   Xiong, Li Xia ^a   Xiao, Liang ^b   Meng, Chuang ^a   Qi, Guan Yun ^a   Li, Wen Lin ^a  

^a NANCHANG UNIVERSITY   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Breast cancer; Caveolin 1; Epidermal growth factor; Fibroblast; Fibroblast specific protein 1; Stromal cell derived factor 1; Tumor protein 53 induced glycolysis and apoptosis regulator

Indexed keywords

CALVASCULIN; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; TUMOR PROTEIN; TUMOR PROTEIN 53 INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR; UNCLASSIFIED DRUG; C12ORF5 PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; FSP1 PROTEIN, HUMAN; MESSENGER RNA; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; GLYCOLYSIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CALCIUM-BINDING PROTEINS; CAVEOLIN 1; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84954271708     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4610     Document Type: Article

References (38)

1. Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, Wakasa T, Shintaku M, Tsuyuki S, Inamoto T and Toi M: Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 102: 1590-1596, 2011.
2. Chiu WT, Lee HT, Huang FJ, Aldape KD, Tao J, Steeg PS, Chou CY, Lu Z, Xie K and Huang S: Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res 71: 4932-4943, 2011.
3. Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG and Lisanti MP: Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 13: 213-225, 2011.
4. Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, Pestell RG, Sotiga F, Rui H and Lisanti MP: Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol Ther 8: 1071-1079, 2009.
5. Patani N, Martin LA, Reis-Filho JS and Dowsett M: The role of caveolin-1 in human breast cancer. Brest Cancer Res Treat 131: 1-15, 2013.
6. Sotgia F, Martinez-Outschoorn UE, Howell A, Prestell RG, Pavlides S and Lisanti MP: Caveolin-1 and cancer metabolism in the tumor microenvironment: Markers, models, and mechanisms. Annu Rev Pathol 7: 423-467, 2012.
7. Du C, Chen L, Zhang HJ, Wang ZC, Liu WC, Xie XD and Xie MJ: Caveolin-1 limits the contribution of BKCa channel to MCF-7 breast cancer cell proliferation and invasion. Int J Mol Sci 15: 20706-20722, 2014.
8. Paola C: Cancer associated fibroblasts: The dark side of the coin. Am J Cancer Res 1: 482-497, 2011.
9. Buckley CD: Why does chronic inflammation persist: An unexpected role for fibroblasts. Immunol Lett 138: 12-14, 2011.
10. Wang Z, Wang N, Li W, Liu P, Chen Q, Situ H, Zhong S, Guo L, Lin Y, Shen J, and Chen J: Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway. Carcinogenesis 35: 2346-2356, 2014.
11. Jen KY and Cheung VG: Identification of novel p53 target genes in ionizing radiation response. Cancer Res 65: 7666-7673, 2005.
12. Lee P, Vousden KH and Cheung EC: TIGAR, TIGAR, burning bright. Cancer Metab 2: 1, 2014.
13. Yamaguchi H and Sakai R: Direct interaction between carcinoma cells and cancer associated fibroblasts for the regulation of cancer invasion. Cancers 7: 2054-2062, 2015.
14. Witkiewicz AK, Dasgupta A, Sammons S, Er O, Potoczek MB, Guiles F, Sotgia F, Brody JR, Mitchell EP and Lisanti MP: Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 10: 135-43, 2010.
15. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR and Lisanti MP: An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 74: 2023-2034, 2009.
16. EI-Gendi SM, Mostafa MF and EI-Gendi AM: Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res 18: 459-469, 2012.
17. Shan-Wei W, Kan-Lun X, Shu-Qin R, Li-Li Z and Li-Rong C: Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer. Breast Care (Basel) 7: 477-483, 2012.
18. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR and Lisanti MP: An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8: 2420-2424, 2009.
19. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Wiktkiewicz AK, Martinez-Cantarin MP, Flomenberg N, et al: Tumor cells induce the cancer associated fibroblast phenotype via Caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 9: 2423-2433, 2010.
20. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8: 3984-4001, 2009.
21. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M and Marini FC: Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27: 2614-2623, 2009.
22. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313, 2008.
23. Jezierska-Drutel A, Rosenzweig SA and Neumann CA: Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119: 107-125, 2013.
24. Engl T, Relja B, Marian D, Blumenberg C, Muller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D and Blaheta RA: CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 8: 290-301, 2006.
25. Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X, Eesalu T, Kohn W and Tang S: Akt activation,but not extracellular bignal-reguhted kinase activation,is required for SDF-lalpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 3: 227-236, 2005.
26. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCLl2 secretion. Cell 121: 335-348, 2005.
27. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H and Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638,1996.
28. Lewellis SW and Knaut H: Attractive guidance: how the chemokine SDF1/CXCL12 guides different cells to different locations. Semin Cell Dev Bio 23: 333-340, 2012.
29. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
30. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Juang H, Porter D, Hu M, Chin L, Richardson A, et al: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32, 2004.
31. Li CF, Ma Y, Wei YZ and Xue Y: Relationship between VEGF, EGF and invasion, metastasis of gastric cancer cells. Chin J Cancer Res 21: 122-129, 2009.
32. Baek MK, Kim MH, Jang HJ, Park JS, Chung IJ, Shin BA, Ahn BW and Jung YD: EGF stimulates uPAR expression and cell invasiveness through ERK, AP-l, and NF-kappaB signaling in human gastric carcinoma cells. Oncol Rep 20: 1569-1575, 2008.
33. Hardwicke J, Schmaljohann D, Boyce D and Thomas D: Epidermal growth factor therapy and wound healing-past, present and future perspectives. Surgeon 6: 172-177, 2008.
34. Helfman DM, Kim EJ, Lukanidin E and Grigorian M: The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92: 1955-1958, 2005.
35. Tarabykina S, Griffiths TR, Tulchinsky E, Mellon JK, Bronstein IB and Kriajevska M: Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets 7: 217-228, 2007.
36. Grum-Schwensen B, Klingelhofer J, Berg CH, El-Naaman C, Grigorian M, Lukanidin E and Ambartsumian N: Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Cancer Res 65: 3772-3780, 2005.
37. Green DR and Chipuk JE: p53 and metabolism: Inside the TIGAR. Cell 126: 30-32, 2006.
38. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E and Vousden KH: TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120, 2006.